Cetero Research Cetero Research is an industry leading CRO in clinical pharmacology, bioanalytical, and specialty Phase II-IV services. With more than 25 years of experience from our founding companies, we have conducted more clinical...
VirtualScopics VirtualScopics is a leading imaging core lab providing central reads and quantitative imaging solutions for drug and medical device clinical trials. Therapeutic area expertise includes: oncology, rheumatoid arthritis,...
Covance Covance is one of the world’s largest and most comprehensive drug development services companies with more than 10,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance...
Biopharmaceutical Services
Customized and committed to clients large or small, Covance recognizes your development program is as unique as the products you bring to our facilities....
cGMP Cell Banking Services
Covance offers complete cGMP master (MCB) and working (WCB) cell bank generation, storage and cell line biosafety testing. As one of the first CROs to...
cGMP Stability and Release Testing
Covance offers cGMP-compliant stability and release services for both large and small molecule drug API and drug products globally. Covance can help you...
Archimedes, Inc. Archimedes enables clients to conduct realistic clinical trial simulations for any drug or intervention and determine the health economics and outcomes. Lower the risk of trial failure, comparative and cost effectiveness,...
Clinical Trial Simulation
Archimedes enables clients to lower their risk of clinical trial failure. Through scientifically and clinically validated mathematical modeling Archimedes...
Comparative Effectiveness Studies
Archimedes enables clients to conduct realistic clinical trial simulations to distinguish their drug’s clinical and economic benefits from standard...
Cost Effectiveness Studies
Archimedes enables clients to deliver substantial value to their organization by more accurately answering critical question about efficacy, costs, and...
Pacific BioLabs Pacific BioLabs is a contract research organization (CRO) offering testing and research support services to its clients in the medical device, pharm/biopharm, and other industries. Specializing in the biological sciences,...
DRUG DEVELOPMENT PROCESS
Drug development is a high-risk enterprise. The typical new drug takes 10-12 years to get to market and costs up to $500 million. Pharmaceutical companies...
Takeda Pharmaceutical Company Takeda is a research-based global pharmaceutical company. As the largest pharmaceutical company in Japan and one of the global leaders of the industry. Setting our management philosophy, " Takeda-ism " as the basis of...
ACTOS
Insulin sensitizer for type 2 diabetes mellitus
Targacept, Inc. Targacept is developing a diverse pipeline of innovative NNR Therapeutics(TM) for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal...
AZD1446 (TC-6683)
AZD1446 (TC-6683) is a novel small molecule that, like AZD3480, acts selectively on the α4ß2 NNR subtype. AZD1446 is the most advanced product candidate...
AZD3480 (TC-1734)
AZD3480 (TC-1734) is a novel small molecule that acts selectively on the alpha4beta2 (α4ß2) NNR subtype. The company we entered into a collaborative...
TC-5214 - Major Depressive Disorder
TC-5214 is a nicotinic channel blocker that modulates the activity of various NNR subtypes thought to be involved in this increased cholinergic tone.TC-5214...
New partnerships in drug development spur trust as well as cost efficiency.
With the rise of biotech firms, the establishment of new compounds in the early drug development pipeline, and outsourcing to Pharmaceutical Drug Development services have become commonplace. Yet, these firms are emerging as trusted partners in regulatory matters internationally, experts in specific diagnostic trials, and proficient in streamlining early phase trials. And, with typical drug development from discovery to market ringing at just short of $1 billion USD and 12 years, drug development services become an attractive option to offset the costs of time and resources.
Best in Class Pharmaceutical Drug Development feature:
Full-scale simulations for physiological and economical modeling
The ability to take over development projects mid-phase and integrate data and results
Regulatory expertise to ensure compliance at all levels of bureaucratic and governmental oversight
Top Considerations Before Outsourcing Pharmaceutical Drug Development:
Many vendors espouse the virtues of outsourcing drug development to free up cash and resources to allocate to more core competencies for drug company clients, such as manufacturing. If this is your reason for buying, it is crucial to ensure a financial plan that sees the redeployment of internal resources to those critical areas. A modeling of the outsourced plan and budget should include a boost in productivity in a corresponding business unit due to the resources reallocation.
Key Vendors to Consider
1. Based in Miami, Cetero’s Central Laboratory anchors their Clinical Pharmacology unit. The Clinical Laboratory is licensed in areas including Hematology, Chemistry, Coagulation, Urinalysis, Special Chemistry, Serology, and Viral Markers. Focusing heavily in allergy and asthma research, Cetero is the only professional CRO that has developed and fully validated models in the Environmental Exposure Chambers (EEC) for cGCP compliant studies. The EEC Model is a validated, rapid and FDA-accepted clinical solution for the development of small molecule drugs, immunotherapies and therapeutic devices.
2. With their Clinical Trial Simulation, Archimedes, Inc. aims to save clients valuable cash assets by modeling outcomes prior to full phase execution. Archimedes enables clients to conduct realistic clinical trial simulations to distinguish their drug’s clinical and economic benefits from standard treatments and competitor drugs. Additionally, the firm focuses on comparative effectiveness of one drug to an emerging solution, and helps clients more accurately answer questions regarding costs and target markets through healthcare modeling.
3. Specializing in antibodies, Covance prides itself on delivering solutions to client’s clinical challenges with unique solution sets, including biopharmaceutical services, clinical and nonclinical services, strategic partnering and other strategies for development. The company asserts that it generates more drug development data for the regulatory evaluation of efficacy than any other firm in the world. As so, Convance maintains a long history of successful collaborative relationships to drive down R&D costs.
4. Symyx Isentris for SharePoint is a collection of Microsoft SharePoint Web parts that improves project team data collaboration in analysis and gives scientists access to real-time project information. Additionally, Symyx provides a host of software solutions that aid in database access, decision support, lab execution and analysis, cheminformatics and others. Symyx is dedicated to supporting their product offerings through a variety of portals for quick problem resolution. The firm will also consult on software implementation and correct solution choosing.
5.Therapure Biopharma’s Drug Development focuses on the development of therapeutic proteins – representing one-third of all new drug developments. The firm provides end-to-end trial services, process and test development, as well as final release testing, filling, packaging and shipping services. Therapure has compiled an extensive listing of proprietary products based on hemoglobin—most designed to treat infectious disease, anemia, and cancer. Protein modifica-tion technology allows clients to boost efficacy and half-life.
Pharmaceutical Drug Development Definition: Pharmaceutical Drug Development offers "outsourced" research support to the pharmaceutical and biotechnology industries. These “outsourced” firms provide clients with research services to aid in the drug and medical device research and development process, including product development, formulation and manufacturing; clinical trial management (preclinical through phase IV); clinical, medical and safety monitoring; preclinical, toxicology, and clinical laboratory services for processing trial samples; data management, biostatistics and biomedical writing services, especially in preparation for an FDA New Drug Application or NDA. See also Clinical Research Organizations or CROs.
Renal impairment trials are typically included as part of the clinical development of a drug. This whitepaper, based on years of experience executing renal trials, provides practical information for pharma and biotech professionals. In this whitepaper, you’ll gain knowledge of:
- Similarities and differences between FDA and EMEA guidance on renal trials.
- Recommended timing for renal ...
Hepatic impairment trials are generally included as part of the clinical development of a drug. This whitepaper, based on years of experience executing hepatic trials, provides practical information for pharma and biotech professionals. In this whitepaper, you’ll gain knowledge of:
- Similarities and differences between FDA and EMEA guidance on hepatic trials.
- Categorization standards ...
Drug administration is a common cause of torsades de pointes (TdP). Among these drugs are the QT-prolonging antiarrhythmics (e.g. quinidine, sotalol, dofetilide, ibutilide) and a wide range of drugs developed for non-cardiovascular indications (e.g. erythromycin, fluoroquinolones, thioridazine) and other antipsychotics. An up-to-date list of drugs inducing TdP is available on the Internet. The ...
The Netherlands offers pharmaceutical firms a favorable environment for receiving expedited study review. Clinical studies can be rapidly initiated in The Netherlands due to Dutch government regulations for clinical research. Based on years of experience operating in the Netherlands, this whitepaper will:
- Outline the regulatory guidelines for studies in The Netherlands.
- Highlight ...
A large pharmaceutical company was in the process of designing a Phase III clinical trial for
a diabetic agent. In the trial design phase, they needed to develop a strategy to maximize
the probability that the population they enrolled would experience enough MACEs to ensure
that the company had appropriately powered the trial.
Selection of a pre-clinical drug candidate for advancement to clinical trials is a critical
decision. Large clinical trials often require years of observation and cost millions of dollars.
When a clinical trial runs over schedule, drug developers can lose over $600,000 a day in
sales for smaller niche products and over $8,000,000 a day for blockbuster drugs. Adding to
this problem, the ...
Historically, vaccines are medicines that deliver or generate antigens that induce specic, active, and protective immunity against infectious diseases. Antigens stimulate the immune system to activate cells and organs that induce active immunity, characterized by production of antibodies (humoral immunity) and/or cytotoxic T-cells (cell mediated immunity). Vaccines “train” the body’s immune ...
The last decade has seen rapid technological progress but with increasing demands for safe and efficacious drugs, technological solutions that reduce the barriers to clinical success will be of more interest than those that simply shift the bottlenecks and necessitate new compromises in the discovery and development process.
Too often insufficient predictivity of early clinical data leads to unnecessary expenses at later stages of development. Explore the benefits of considering new approaches to clinical drug development.
Why consider new approaches to clinical drug development?
In a standard clinical development program, the confidence level of making the best decision (go, no-go) prior to conducting a first- ...
Outsourcing is one of the commonly used approaches by pharmaceutical companies. Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit growth. There are a number of trends and forces within the pharmaceutical industry that are causing companies to rethink their approaches to growth and cost management.
Have you ever wanted to run trials for 10 years, 20 years or 60 years? Or run huge trials with hundreds of thousands or even millions of people?
Math is ...
Company descriptions and contact
information are quoted
from the company's website or other promotional information. JAZ'D is not responsible for
the accuracy
of this information. Unless specifically noted, JAZ'D is not sponsored by, affiliated with
or otherwise
connected with any of the listed companies.